Introduction
============

Rheumatoid arthritis (RA), one of the most prevalent chronic inflammatory diseases, is characterized by damage to cartilage and bone leading to disability ([@B28]). It is a substantial burden for individuals and society, with up to 0.5% of the global population affected ([@B23]), and the identification of novel therapeutic strategies to control inflammation and reduce severe consequences is increasingly imperative. The pathogenesis of RA is closely associated with genetic and environmental factors, with the major histocompatibility complex (MHC) region at 6p21 contributing to 30--50% of genetic liability to RA ([@B35]; [@B25]; [@B30]). Cigarette smoking also plays an important role in RA risk ([@B29]).

Rheumatoid arthritis risk was recently shown to be associated with epigenetic regulation including DNA methylation, histone modification, and transcriptional/post-transcriptional regulation ([@B18]). MicroRNAs (miRNAs), which are the most widely studied class of non-coding RNAs, function in the post-transcriptional regulation of gene expression by controlling the translation of mRNA into proteins ([@B15]). Moreover, miRNAs play a significant role in regulating biological processes, including proliferation, apoptosis, and development ([@B8]).

A growing body of evidence indicates that single nucleotide polymorphisms (SNPs) in miRNAs may affect RA susceptibility because certain SNPs located in miRNA encoding genes can alter miRNA expression, pri-miRNA and pre-miRNA processing, or miRNA--mRNA interactions ([@B11]; [@B5]).

[@B4] reported that the C allele of rs2910164 in miR-146a has a protective role in the pathogenesis of RA. However, [@B26] reported no significant association between miR-146a polymorphisms and RA susceptibility or progression. With regard to miR-499, the effect of C allele of rs3746444 on RA risk is also controversial ([@B7]; [@B39]). The association between miRNA polymorphisms and susceptibility to RA remain unclear. Because of increasing number of case-control studies published, an updated meta-analysis is required to evaluate the relationship between miRNA polymorphisms and RA, including subgroup analyses investigating ethnicity-specific effects.

Materials and Methods {#s1}
=====================

Literature Search Strategy
--------------------------

A comprehensive search of the PubMed and Embase databases was performed to retrieve studies investigating the association between miRNA polymorphisms and RA susceptibility published in English up to December 8, 2017. The search terms were as follows: "rheumatoid arthritis" "arthritis" "microRNA" "miRNAs" "polymorphism" and "polymorphisms." Relevant journals and the references of the included studies were also reviewed.

Inclusion and Exclusion Criteria
--------------------------------

The inclusion criteria of our meta-analysis were as follows: (1) case-control studies; (2) investigation of miRNA polymorphisms and RA susceptibility; (3) detailed numbers of alleles and genotypes between cases and controls; (4) full text published in English; (5) control group consistent with Hardy-Weinberg Equilibrium (HWE); and (6) any specific miRNA with at least two case-control studies to evaluate the association between single nuclear polymorphism and RA susceptibility.

The exclusion criteria were as follows: (1) reviews or case reports without controls; (2) no available data reported; and (3) duplicated reports.

Data Extraction
---------------

Two investigators (Zhou and Jiang) screened the literature and extracted data independently according to the inclusion and exclusion criteria. Discrepancies and differences were resolved by a third investigator (Zhu) until consensus was reached. The following data were retrieved: author list, year of publication, ethnicity, sample size, alleles, genotype of each gene polymorphism, and HWE.

Data Synthesis and Statistical Analysis
---------------------------------------

The odds ratios (ORs) with their corresponding 95% confidence intervals (CIs) were used to assess the strength of the association between polymorphisms in miRNAs and RA. For miR-146a rs2910164 G \> C, the dominant (GC + CC vs. GG), recessive (CC vs. GC + GG), heterozygous (GC vs. GG), homozygous (CC vs. GG), and allelic (C vs. G) genetic models were used to calculate pooled ORs. These models were also used to evaluate the miR-499 rs3746444 T \> C polymorphism, including the dominant (TC + CC vs. TT), recessive (CC vs. TC + TT), heterozygous (TC vs. TT), homozygous (CC vs. TT), and allelic (C vs. T) models.

The Chi square-based *Q*-test was used to assess the between-study heterogeneity and a *P*-value of 0.1 was considered to indicate significant heterogeneity among studies ([@B19]). The I^2^ metric value was also used to describe the proportion of total variation in study estimates due to heterogeneity, with values of 25, 50, and 75% considered as evidence of low, moderate, and high heterogeneity, respectively ([@B16]). The pooled OR estimation of each study was calculated by the fixed-effects model (the Mantel--Haenszel method) when the *P*-value was \>0.1 and I^2^ was \<50% ([@B22]). Otherwise, the random-effects model (the DerSimonian and Laird method) was used ([@B6]). Subgroup analyses according to ethnicity were also performed to calculate ethnic-specific ORs. The HWE was tested for each study by comparing the observed and expected genotype frequencies of the control group (Chi-square test). Publication bias was evaluated with Egger's linear regression and Begg's funnel plots ([@B14]). Statistical analyses were performed using the Stata software (version 14.1; Stata Corp., College Station, TX, United States) with a two-sided *P*-value. *P* \< 0.05 was considered significant.

Results
=======

Study Characteristics
---------------------

The results of the systematic search and selection performed according to the inclusion and exclusion criteria are shown in Figure [1](#F1){ref-type="fig"}. A total of 13 articles with 2660 cases and 4098 controls were finally included in the meta-analysis ([@B3]; [@B36], [@B37]; [@B17]; [@B7]; [@B12]; [@B39]; [@B41]; [@B2]; [@B4]; [@B31]; [@B9]; [@B13]). The 13 articles comprised 16 studies, including 9 studies on miR-146a rs2910164 and 7 studies on miR-499 rs3746444. Table [1](#T1){ref-type="table"} shows the characteristics of the retrieved studies. Various genotyping methods were used, including PCR-RFLP, TaqMan, and PCR. The genotype distribution of the controls in all studies was consistent with HWE, except one study from the miR-146a polymorphism group ([@B7]) and two from the miR-499 polymorphism group ([@B12]; [@B31]).

![Flow chart showing the detailed steps for literature selection.](fphys-09-01604-g001){#F1}

###### 

The basic characteristics of the retrieved studies.

  First author          Year   Country   Ethnicity   Genotyping method   Sample size   Genotypes (case/control)   HWE (P)                                                
  --------------------- ------ --------- ----------- ------------------- ------------- -------------------------- --------- -------- -------- -------- -------- -------- ---------
  **miR-146a G \> C**                                                                                                                                                    
  Hasssine              2017   Tunisia   Caucasian   PCR-RFLP            165           150                        94        63       8        68       69       13       0.441
  Ciccacci              2016   Italia    Caucasian   TaqMan PCR          192           298                        109       69       14       158      117      23       0.836
  Bogunia-Kubik         2016   Poland    Caucasian   PCR--RFLP           111           130                        72        32       7        88       36       6        0.361
  Zhou                  2015   China     Asian       PCR                 598           821                        114       283      201      151      385      285      0.296
  El-Shal               2013   Egypt     Caucasian   PCR-RFLP            217           245                        30        103      84       15       119      111      0.021
  Hashemi               2013   Iran      Caucasian   T-ARMS-PCR          104           110                        57        39       8        64       37       9        0.280
  Jimenez-Morales       2012   China     Asian       TaqMan PCR          210           531                        102       80       28       236      229      66       0.369
  Yang                  2011   China     Asian       PCR-RFLP            208           240                        28        95       85       30       116      94       0.529
  Chatzikyriakidou      2010   Greece    Caucasian   PCR-SSCP            136           147                        73        53       10       80       53       14       0.240
                                                                                                                  **TT**    **CT**   **CC**   **TT**   **CT**   **CC**   
  **miR-499a T \> C**                                                                                                                                                    
  Fattah                2017   Egypt     Caucasian   PCR-RFLP            100           100                        33        53       14       49       41       10       0.742
  Yang                  2016   China     Asian       TaqMan PCR          386           576                        282       99       5        443      125      8        0.807
  Toraih                2016   Egypt     Caucasian   TaqMan PCR          95            200                        50        15       30       82       68       50       \<0.001
  El-Shal               2013   Egypt     Caucasian   PCR-RFLP            217           245                        113       93       11       167      70       8        0.841
  Zhang                 2013   China     Asian       MALDI-TOF MS        206           466                        159       44       3        346      110      10       0.719
  Hashemi               2013   Iran      Caucasian   T-ARMS-PCR          104           110                        46        32       26       74       25       11       \<0.001
  Yang                  2011   China     Asian       PCR-RFLP            208           240                        159       42       7        182      53       5        0.624
                                                                                                                                                                         

Meta-Analysis
-------------

In all the populations, the miR-146a rs2910164 G \> C polymorphism was not significantly associated with increased susceptibility to RA (C vs. G: OR = 0.95, 95% CI = 0.86--1.04, P~h~ = 0.66; CC vs. GG: OR = 0.91, 95% CI = 0.75--1.12, P~h~ = 0.87; GC vs. GG: OR = 0.91, 95% CI = 0.78--1.05, P~h~ = 0.74; GC/CC vs. GG: OR = 0.91, 95% CI = 0.79--1.04, P~h~ = 0.69; CC vs. GC/GG: OR = 0.97, 95% CI = 0.82--1.14, P~h~ = 0.896). Subgroup analysis based on ethnicity showed no significant association between the miR-146a C/G polymorphism and susceptibility to RA in the Asian and Caucasian populations (*P* \> 0.05) (Table [2](#T2){ref-type="table"} and Figures [2A,B](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}).

###### 

Meta-analysis results of the miR-146a rs3027898 and miR-499a rs3746444 polymorphisms with genetic susceptibility to rheumatoid arthritis.

  Variables             *N*               C vs. G             CC vs. GG       GC vs. GG          GC/CC vs. GG        CC vs. GC/GG                                                                                                                                                               
  --------------------- ----------------- ------------------- --------------- ------------------ ------------------- -------------- ----------------- ------------------- ------------- ----------------- ------------------- ------------- ----------------- ------------------- ------------- -----
  **miR-146a G \> C**                                                                                                                                                                                                                                                                           
  Caucasian             6                 0.92 (0.80--1.05)   0.486           0.0                0.88 (0.64--1.20)   0.692          0.0               0.89 (0.74--1.06)   0.545         0.0               0.89 (0.75--1.05)   0.476         0.0               0.93 (0.69--1.26)   0.772         0
  Asian                 2                 0.98 (0.86--1.11)   0.743           0.0                0.94 (0.72--1.23)   0.915          0.0               0.95 (0.74--1.23)   0.754         0.0               0.95 (0.75--1.21)   0.896         0.0               0.98 (0.81--1.19)   0.593         0
  All ethnicity         8                 0.95 (0.86--1.04)   0.660           0.0                0.91 (0.75--1.12)   0.870          0.0               0.91 (0.78--1.05)   0.740         0.0               0.91 (0.79--1.04)   0.690         0.0               0.97 (0.82--1.14)   0.896         0
                                                                                                                                                                                                                                                                                                
                        **C vs. T**       **CC vs. TT**       **TC vs. TT**   **TC/CC vs. TT**   **CC vs. TC/TT**                                                                                                                                                                               
                        **OR (95% Cl)**   **P~h~**            **I^2^(%)**     **OR (95% Cl)**    **P~h~**            **I^2^(%)**    **OR (95% Cl)**   **P~h~**            **I^2^(%)**   **OR (95% Cl)**   **P~h~**            **I^2^(%)**   **OR (95% Cl)**   **P~h~**            **I^2^(%)**   
                                                                                                                                                                                                                                                                                                
  **miR-499a T \> C**                                                                                                                                                                                                                                                                           
  Caucasian             2                 1.64 (1.28--2.11)   0.740           0.0                2.06 (1.06--3.97)   0.973          0.0               1.95 (1.40--2.71)   0.951         0.0               1.96 (1.43--2.69)   0.977         0.0               1.52 (0.81--2.86)   0.906         0.0
  Asian                 3                 1.04 (0.86--1.25)   0.351           4.4                1.03 (0.53--2.01)   0.598          0.0               1.05 (0.85--1.29)   0.293         18.5              1.05 (0.85--1.29)   0.312         14.2              1.03 (0.53--2.01)   0.592         0
  All ethnicity         5                 1.22 (1.05--1.42)   0.035           61.2               1.46 (0.92--2.32)   0.558          0.0               1.26 (1.05--1.50)   0.016         67.1              1.26 (1.07--1.50)   0.011         69.2              1.26 (0.80--1.99)   0.790         0.0

CI, confidence interval, OR, odds ratio, I

2

= the variation in OR attributable to heterogeneity.

![**(A)** Forest plot for association between miR-146a rs302789 polymorphisms and risk of rheumatoid arthritis under allele genetic model (C vs. G) after stratification analysis by ethnicity. **(B)** Forest plot for association between miR--146a rs302789 polymorphisms and risk of rheumatoid arthritis under heterozygote genetic model (GC vs. GG) after stratification analysis by ethnicity.](fphys-09-01604-g002){#F2}

![**(A)** Forest plot for association between miR-146a rs302789 polymorphisms and risk of rheumatoid arthritis under dominant genetic model (GC/CC vs. GG) after stratification analysis by ethnicity. **(B)** The sensitivity analysis for studies of the association between miR--146a rs302789 polymorphisms and risk of rheumatoid arthritis under allele genetic model (C vs. G).](fphys-09-01604-g003){#F3}

A significant association between the miR-499 rs3746444 T \> C polymorphism and RA risk was observed in all populations, as shown in Table [2](#T2){ref-type="table"} (C vs. T: OR = 1.22, 95% CI = 1.05--1.42, P~h~ = 0.035; TC vs. TT: OR = 1.26, 95% CI = 1.05--1.50, P~h~ = 0.016; TC/CC vs. TT: OR = 1.26, 95% CI = 1.07--1.50, P~h~ = 0.011). However, no significant associations were found in CC vs. TT: OR = 1.46, 95% CI = 0.92--2.32, *P* = 0.558 and CC vs. TC/TT: OR = 1.26, 95% CI = 0.8--1.99, *P* = 0.79 (all *P* \> 0.05, Table [2](#T2){ref-type="table"}). Subgroup analysis based on ethnicity showed no significant association between the miR-146a C/T polymorphism and susceptibility to RA in the Asian population (*P* \> 0.05) (Table [2](#T2){ref-type="table"}). However, in the Caucasian population, the C allele in the miR-499 T \> C polymorphism was a contributor to RA susceptibility in some genetic models (C vs. T: OR = 1.64, 95% CI = 1.28--2.11, P~h~ = 0.74; TC vs. TT: OR = 1.95, 95% CI = 1.40--2.71, P~h~ = 0.951; TC/CC vs. TT: OR = 1.96, 95% CI = 1.43--2.69, P~h~ = 0.977) (all *P* \< 0.001, Table [2](#T2){ref-type="table"} and Figures [4A,B](#F4){ref-type="fig"}, [5A](#F5){ref-type="fig"}).

![**(A)** Forest plot for association between miR-499a rs3746444 polymorphisms and risk of rheumatoid arthritis under allele genetic model (C vs. T) after stratification analysis by ethnicity. **(B)** Forest plot for association between miR--499a rs3746444 polymorphisms and risk of rheumatoid arthritis under heterozygote genetic model (TC vs. TT) after stratification analysis by ethnicity.](fphys-09-01604-g004){#F4}

![**(A)** Forest plot for association between miR-499a rs3746444 polymorphisms and risk of rheumatoid arthritis under dominant genetic model (TC/CC vs. TT) after stratification analysis by ethnicity. **(B)** The sensitivity analysis for studies of the association between miR--499a rs3746444 polymorphisms and risk of rheumatoid arthritis under allele genetic model (C vs. G).](fphys-09-01604-g005){#F5}

Sensitivity Analysis and Publication Bias
-----------------------------------------

A leave-one-out analysis was performed to investigate the influence of each individual study on the pooled ORs (Figures [3B](#F3){ref-type="fig"}, [5B](#F5){ref-type="fig"}). The results indicated no significant alteration in the pooled ORs after exclusion of any study on miR-146a rs2910164 G \> C and miR-499 rs3746444 T \> C. Moreover, because of the limited number of studies included (\<10), publication bias was not evaluated.

Discussion
==========

Genetic and epigenetic factors play pivotal roles in cancer and autoimmune diseases. MiRNAs are important for the regulation of the cartilage-invading phenotype of RA synovial fibroblasts, leukocyte activation, and cytokine production, and their roles contribute to our understanding of the mechanisms underlying RA and provide novel therapeutic targets for the treatment of RA ([@B1]).

MiR-146a, one of the most extensively investigated miRNAs, exerts significant effects on cancer and autoimmune diseases. MiR-146a is widely expressed and involved in the differentiation and activation of the innate and adaptive immune systems ([@B24]). It suppresses NF-κB signaling by downregulating the NF-κB signaling transducers interleukin-1 (IL-1) receptor associated kinase 1 and tumor necrosis factor receptor-associated factor 6. Meanwhile, miR-146a directly activates signal transducer and activator of transcription 1 to promote the activity of Treg cells in RA, which mediate the main mechanisms underlying RA ([@B40]). Polymorphisms of miR-146a are associated with various cancers and autoimmune diseases ([@B33]; [@B34]).

A single nucleotide polymorphism consisting of the G/C nucleotide substitution in miR-146a rs2910164 could result in the replacement of a G:U pair by a C:U mismatch ([@B13]). However, the association between mir146a polymorphisms and RA remains controversial. Because of the increasing number of studies, we set strict inclusion and exclusion criteria to avoid potential bias from inadequate studies. Data from [@B27]. were not included in this meta-analysis because the patients were diagnosed as juvenile idiopathic arthritis (JIA), which includes other types of arthritis in young patients. Data from [@B7] were also excluded from the pooled analysis for mir146a because of deviation from HWE in the control group. The results of the updated meta-analysis suggest that mir146a polymorphisms are not associated with RA risk, which is consistent with previous studies ([@B21]; [@B20]).

The mechanism underlying the association between RA and miR-499 was investigated previously. One possible explanation is that mir-499 modulates the expression of regulatory factor X4, thus regulating the human leukocyte antigen DRB1, which is closely associated with RA ([@B32]; [@B36]). Moreover, miR-499 targets IL-17 receptor B, IL-6, and several cytokines, which are important factors involved in RA pathogenesis ([@B38]; [@B7]). Although previous studies demonstrated the association between miR-499 polymorphisms and RA, the limited study number and high heterogeneity decreased the robustness of the conclusions. In the present study, two studies from the miR-499 polymorphism group were excluded from the meta-analysis because the genotype distribution of the controls in all studies was inconsistent with HWE ([@B12]; [@B31]). [@B9] found that miR-499 rs3746444 T \> C is associated with the susceptibility to RA, and the heterozygote is characterized by higher levels of C-reactive protein, anti-cyclic citrullinated peptide, antibody and disease activity score 28 than those of the homozygote ([@B9]). [@B12] also reported that the C allele of the mir-499 rs3746444 polymorphism is a risk factor for RA. Although the overall results of the pooled analysis indicated that the miR-499 T \> C polymorphism was associated with RA risk, the high heterogeneity suggested an insufficient robustness of the conclusion. In the subgroup analysis according to ethnicity, a strong correlation between the miR-499 T \> C polymorphism and RA was observed in the Caucasian group, which suggested that the C allele in the miR-499 T \> C polymorphism was an obvious contributor to RA susceptibility. However, no relationship was observed in the Asian group. The results were in consistency with previous meta-analysis ([@B10]), however, [@B10] drew a conclusion about miR-499 polymorphism group based on three studies including two studies ([@B7]; [@B12]) from the Caucasian group and one ([@B36]) from the Asian group. As increasing number of case-control studies published, this updated meta-analysis retrieved five studies including two ([@B7]; [@B9]) from the Caucasian group and three from Asian group ([@B36], [@B37]; [@B39]). Due to the inconsistency with HWE, two studies ([@B12]; [@B31]) were excluded from the miR-499 polymorphism group, which increased the robustness of this meta-analysis.

The present study had several limitations. Firstly, the variation in sample size and in genotyping methods was a limitation of the study. Secondly, all studies included in our meta-analyses were in accordance with HWE, and because of the limited number of included studies, no publication bias could be tested. Because of the limited quantity and quality of the included studies, the above conclusion needs to be further verified in additional high quality studies.

Conclusion
==========

In conclusion, the present meta-analysis showed no significant association between miR-146a and RA risk, which is consistent with previous studies. However, the present study demonstrated the contribution of the C allele in the miR-499 T \> C polymorphism to RA susceptibility in the Caucasian population, and this association was not present in the Asian population.
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